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METHODOLOGY
A noninvasive optical approach 
for assessing chloride extrusion activity of the 
K–Cl cotransporter KCC2 in neuronal cells
Anastasia Ludwig1,5, Claudio Rivera1,2,3 and Pavel Uvarov4,6* 
Abstract 
Background: Cation-chloride cotransporters (CCCs) are indispensable for maintaining chloride homeostasis in 
multiple cell types, but K–Cl cotransporter KCC2 is the only CCC member with an exclusively neuronal expression in 
mammals. KCC2 is critical for rendering fast hyperpolarizing responses of ionotropic γ-aminobutyric acid and glycine 
receptors in adult neurons, for neuronal migration in the developing central nervous system, and for the formation 
and maintenance of small dendritic protrusions—dendritic spines. Deficit in KCC2 expression and/or activity is associ-
ated with epilepsy and neuropathic pain, and effective strategies are required to search for novel drugs augmenting 
KCC2 function.
Results: We revised current methods to develop a noninvasive optical approach for assessing KCC2 transport activ-
ity using a previously characterized genetically encoded chloride sensor. Our protocol directly assesses dynamics of 
KCC2-mediated chloride efflux and allows measuring genuine KCC2 activity with good spatial and temporal resolu-
tion. As a proof of concept, we used this approach to compare transport activities of the two known KCC2 splice 
isoforms, KCC2a and KCC2b, in mouse neuronal Neuro-2a cells.
Conclusions: Our noninvasive optical protocol proved to be efficient for assessment of furosemide-sensitive chlo-
ride fluxes. Transport activities of the N-terminal splice isoforms KCC2a and KCC2b obtained by the novel approach 
matched to those reported previously using standard methods for measuring chloride fluxes.
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Background
Cation-chloride cotransporters (CCC) form a protein 
family comprising nine members, which play an impor-
tant role in maintaining chloride homeostasis in neu-
ronal, renal, vascular, and other cell types [1]. The only 
member of the CCC family that shows an exclusively 
neuronal expression in mammals is the potassium–
chloride (K–Cl) cotransporter 2 (KCC2) [2]. KCC2 
is indispensable for processes of neuronal migration 
in developing central nervous system, formation and 
maintenance of small dendritic protrusions—dendritic 
spines—in maturing neurons, and for rendering fast 
hyperpolarizing responses of ionotropic γ-aminobutyric 
acid (GABA) and glycine receptors in adult neurons [3]. 
KCC2 deficiency in mature neurons results in elevated 
levels of intracellular chloride concentration [Cl−]i and, 
as a consequence, in attenuated levels of fast hyperpo-
larizing GABAergic and glycinergic inhibition [4]. Two 
protein isoforms KCC2a and KCC2b, which differ only 
in their most N-terminal parts, are encoded by Slc12a5 
gene [5]. Complete genetic ablation of the Slc12a5 gene 
in mice results in severe motor deficits and absence of 
respiratory rhythm, causing death immediately after 
birth [6, 7]. Mice with a specific deletion of the KCC2b 
isoform express only 5–8% of a basal KCC2 protein level, 
exhibit frequent generalized seizures, and die 2–3 weeks 
postnatal [8]. In line with this, three recent studies have 
associated totally five missenses mutations in the human 
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KCC2 gene with cases of epileptic seizures [9–11]. The 
identified KCC2 mutants demonstrate deficit of intrinsic 
transport activity and/or impaired plasmalemmal expres-
sion that considerably reduced chloride extrusion activ-
ity. Neuropathic pain is another severe outcome of the 
impaired GABAergic and glycinergic signaling in central 
pain pathways that is accompanied by downregulation of 
KCC2 expression and/or activity [12]. Development of 
novel drugs augmenting KCC2 activity and/or expression 
after neuronal trauma has been declared as a plausible 
way to treat neuropathic pain [13, 14]. Analysis of chemi-
cal compounds by high-throughput screening (HTS) 
requires reliable and robust methods for assessing KCC2 
transporter activity in neuronal cell lines.
Both electrophysiological and non-electrophysiolog-
ical methods have been used so far to analyze activity 
of the KCC2 protein and its mutant isoforms, though 
direct measuring of chloride fluxes in neuronal cells by 
electrophysiological tools is hampered by the electro-
neutral nature of the K–Cl cotransport. Yet, several indi-
rect methods allow assessing KCC2 transport activity by 
exploiting the fact that a reversal potential for inotropic 
GABAA (EGABA) and glycine (EGly) receptors depend on 
[Cl−]i. Thus, EGABA in a gramicidin-perforated patch 
configuration, which does not disturb [Cl−]i, provides a 
close estimation for a steady-state [Cl−]i level [15]. This 
approach, however, does not necessarily reflect an actual 
extrusion activity of KCC2, as in the conditions of low 
cellular chloride conductance even a relatively weak 
KCC2 activity may significantly decrease [Cl−]i. Another 
approach is to use a whole-cell patch clamp configura-
tion for measuring somatodendritic EGABA gradient in 
conditions of constant Cl− loading via somatic patch 
pipette [16]. One possible caveat of this method is that 
the endogenous KCC2 activity could be significantly dis-
torted by continuous Cl− loading, since SPAK and OSR1 
kinases, which have been previously shown to regulate 
KCC2 activity [17–19], are known to be inhibited by high 
[Cl−]i [20]. One way to avoid this problem is to assess 
efficiency of neuronal Cl− extrusion by measuring a 
recovery time constant (τ) of changes in inhibitory post-
synaptic potential mediated by GABAA receptors (IPSPA) 
after a brief injection of chloride currents by iontopho-
resis [21–23]. The short-term character of Cl− injection 
minimizes an impact on SPAK/OSR1 signaling cascade, 
thus allowing a genuine KCC2 extrusion activity to be 
measured by fitting a curve of IPSPA amplitude recov-
ery immediately after the cessation of Cl− injection. This 
approach has proven to be useful for a pharmacological 
dissection of different components of chloride conduct-
ance in neurons.
Electrophysiological methods described above are 
labor intensive and time consuming, thus lacking a high 
efficiency required for HTS applications and for analyz-
ing activity of multiple KCC2 mutants. Moreover, instead 
of measuring electroneutral KCC2-mediated chloride 
fluxes directly, these methods provide only indirect cor-
relates of the KCC2 transport activity (steady-state [Cl−]i, 
τ, somatodendritic EGABA gradient). Another strategy to 
quantify K–Cl cotransport is to directly analyze dynamics 
of [Cl−]i changes in response to imposed chloride gradi-
ents [24]. One of the approaches to follow [Cl−]i dynam-
ics is to measure intracellular accumulation of radioactive 
chloride (36Cl−), though a relatively long half-life time of 
36Cl− isotope (around 300,000  years) implies a substan-
tial radioactive hazard especially in case of HTS applica-
tions [25]. Intracellular chloride concentration can also 
be measured using chloride-sensitive microelectrodes, 
but such electrodes are difficult for construction and 
cannot be used for HTS applications. Chemical assays 
such as silver chloride gravimetry and atomic absorption 
spectroscopy have been used for measuring [Cl−]i pre-
viously and are still in use [26]. However, both methods 
are tedious since they require multiple washing steps and 
separation of cellular and extracellular solutions. One 
more strategy to overcome problems described above is 
to quantify K–Cl cotransport by analyzing dynamics of 
K+ instead of Cl− component. Indeed, in case of various 
potassium channels and transporters, K+ cation can be 
substituted for its congeners such as radioactive 86Rb+ 
[27, 28], nonradioactive 85Rb+ [29, 30], Tl+ [31–33], and 
NH4+ [34], thus fluxes of these cations instead of K+ can 
be measured. Although such approaches have been suc-
cessfully exploited for CCC members in HTS applica-
tions in nonneuronal cell lines, their implementation for 
neuronal cells has so far been limited due to same tech-
nical reasons as for the described above Cl-flux methods 
(poor survival of neuronal cells after multiple washing 
steps, poor loading and high toxicity of Tl+ sensitive 
dyes, a relatively high amount of cells required for an 
analysis, health hazard issues in case of radioactive 86Rb+ 
isotope). Moreover, neuronal expression of numerous K+ 
channels and transporters impedes an accurate assess-
ment of K+-fluxes attributed specifically to KCC2. These 
methods provide low temporal resolution and lack spatial 
resolution needed for measuring KCC2 activity in small 
neuronal compartments—axons, dendrites, and dendritic 
spines.
To overcome limitations inherent to the electrophysi-
ological and K+ flux-related methods, development of a 
new class of tools—genetically encoded chloride sensors 
(GECS)—has been commenced a decade and a half ago 
[35]. At that time, it was found that fluorescent char-
acteristics of green fluorescent protein (GFP) variants 
depend on the concentration of halide anions [36]. Since 
then various GECS have been characterized: YFP-H148Q 
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[37] with multiple variants [38] including a membrane-
targeted mbYFPQS [39], Clomeleon [40] and its recent 
modification SuperClomeleon [41], ClopHensor [42] with 
several modifications [43] including the neuronal variant 
ClopHensorN [44], as well as Cl-sensor [45] with its gly-
cine receptor (GlyR)-linked variant BioSensor-GlyR [46]. 
Most of the above-mentioned chloride sensors are fusion 
proteins comprising a halide-sensitive (YFP, E2GFP) and 
a halide-insensitive (CFP, DsRed, tdTomato) parts con-
nected by a short linker. Such design allows ratiometric 
measurements to be done in either FRET or non-FRET 
mode. A major advantage of GECS is that they make pos-
sible noninvasive [Cl−]i measurements in neuronal somas 
and compartments (axons, dendritic spines and shafts). 
Moreover, many cells can be recorded simultaneously 
providing a high efficiency required for HTS applications 
[13]. Furthermore, stable cell lines encoding GECS can be 
easily propagated in quantities required for screening of 
large libraries of chemical compounds. Transgenic mice 
expressing YFP [47], Clomeleon [48], and Cl-sensor [49] 
have also proved to be useful for studying Cl− dynamics 
in brain slices and in dissociated neuronal cultures.
A major disadvantage of the YFP-based chloride sensors 
is their relatively high sensitivity to protons [37, 40, 43, 45, 
47, 50–52]. Indeed, inaccuracy in determination of [Cl−]i 
depends on the basal [Cl−]i and pHi and may reach up to 
10  mM [40, 45] at physiologically relevant low [Cl−]i [44, 
53]. To measure [Cl−]i more precisely, independent pHi 
recording using pH-sensitive dyes or genetically-encoded 
pH sensors is necessary, especially in the cases of signifi-
cant pHi fluctuations induced by neuronal activity [54]. 
This can be accomplished by using ClopHensor—a chlo-
ride sensor that allows simultaneous noninvasive [Cl−]i and 
pHi measurements. Even though ClopHensor and its vari-
ants [43] provide more accurate [Cl−]i measurements [42, 
44], usage of these sensors is more technically demanding 
compared to other GECS for several reasons: (1) three exci-
tation wavelengths instead of two, normally used for other 
GECS, are needed for acquisition; (2) usage of laser light 
sources is preferable [42, 44] because two excitation wave-
lengths for ClopHensor (488-nm pH-dependent E2GFP sig-
nal and 458-nm pH-independent E2GFP signal) are closely 
set; (3) additional photodiode, which measures laser power 
fluctuations during acquisition, has to be installed into 
optic paths to correct fluorescence ratios [42, 44]; and (4) a 
relatively complex data analysis [35].
In the current study, we describe a protocol for nonin-
vasive measuring of KCC2 transport activity in neuronal 
cells. We have attempted to combine advantages and 
to avoid known weaknesses of the previously described 
methods for assaying KCC2 transport activity. Our 
approach measures KCC2-mediated Cl− fluxes in a 
robust way using a previously characterized genetically 
encoded chloride sensor Cl-sensor. In contrast to Clo-
pHensor and its derivatives, usage of Cl-sensor requires 
neither expensive laser light sources nor a confocal setup 
[45, 55, 56] and can be accomplished with a conven-
tional fluorescence microscope [57]. Moreover, instead of 
measuring steady-state [Cl−]i levels—indirect correlate of 
the KCC2 activity, our protocol directly assesses dynam-
ics of KCC2-mediated Cl− fluxes. This new approach can 
be used for screening chemical compounds augmenting 
KCC2 activity as well as for assessing a transport activ-
ity of KCC2 mutant variants. As a proof of concept, we 
use this method to compare transport activities of the 
two previously characterized KCC2 isoforms, KCC2a and 
KCC2b [5, 58] in neuronal type Neuro-2a cells.
Methods
DNA constructs
Cl-sensor consists of the chloride sensing YFP triple 
mutant YFP-(H148Q/I152L/V163S) connected by a 20 
amino acid linker (GSGSGENLYFAGGGSGGSGS) to 
the chloride-insensitive CFP [45] (Fig.  1a). Cl-sensor in 
pGW-CMV expression vector (British Biotechnology, 
Oxford, UK) and human GlyR α1 subunit expression 
construct were described previously [55, 59]. Expression 
constructs for KCC2a and KCC2b splice variants of the 
neuronal KCC2 cotransporter were characterized pre-
viously [5, 58]. pcDNA3.1(−) plasmid (Invitrogen) was 
used for a mock transfection control.
Cell lines and transfection
Mouse neuroblastoma Neuro-2a cells (CCL-131, Ameri-
can Type Culture Collection, Manassas, VA) were cul-
tured in 35  mm culture dishes in Dulbecco’s Modified 
Eagle’s Medium (DMEM) supplemented with 10% fetal 
bovine serum and 100 units/ml penicillin plus 100 μg/ml 
streptomycin antibiotics mix. For imaging experiments, 
the cells were plated on 1-cm glass coverslips, transfected 
next day with corresponding DNA constructs using Lipo-
fectamine 2000 (Life Technologies) according to manu-
facturer’s instructions, and used for Cl− imaging 24–48 h 
after transfection. The transfection mixes differed in the 
experiments presented in Figs. 2, 3, and 4, but total DNA 
amount per one reaction (35 mm plate) was always kept 
2.15 µg, of which Cl-sensor constituted 0.25 µg. Since it is 
important to maintain the same amount of total DNA in 
all transfection reactions, the empty vector pcDNA3.1(−) 
was added when needed to adjust the total DNA amount 
to 2.15  µg. So, for the calibration curve experiments 
(Fig. 2), the cultures were co-transfected with 0.25 µg of 
Cl-sensor and 1.9 µg of pcDNA3.1(−). In the experiments 
intended to optimize the loading procedure (Fig. 3), the 
transfection mix contained 0.25  µg of the Cl-sensor, 
0.7  µg of the human GlyR α1 subunit construct, 0.7  µg 
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of the KCC2 isoform, and 0.5 µg of the pcDNA3.1(−). In 
the experiments assessing the chloride extrusion activity 
of the KCC2a and KCC2b isoforms (Fig. 4a, b), the trans-
fection mix contained 0.25 µg of the Cl-sensor, 0.7 µg of 
the human GlyR α1 subunit expression construct, 0.7 µg 
of either of the KCC2 isoforms (Fig. 4a, b), and 0.5 µg of 
the pcDNA3.1(−). For the corresponding control reac-
tion (Fig.  4c, no KCC2), the transfection mix contained 
0.25 µg of the Cl-sensor construct, 0.7 µg of the human 
GlyR α1 subunit expression construct, and 1.2  µg of 
pcDNA3.1(−). Our approach is based on simultaneous 
co-expression of multiple constructs that is a reasonable 
strategy given previous work [56].
Fluorescence imaging setup
The imaging setup for [Cl−]i measurements in neu-
ronal cells transfected with Cl-sensor was based on the 
inverted Olympus fluorescence microscope (IX71, Olym-
pus, France) and was described previously [57] (Fig. 1b). 
Briefly, Neuro-2a cells grown on coverslips and express-
ing Cl-sensor were exited using an X-Cite Series 120Q 
(Lumen Dynamics Group Inc., Ontario, Canada) light 
source through the 430(24) nm and 500(20) nm excita-
tion filters (ET430/24× and ET500/20× filters were pur-
chased as a part of the #59217 set, Chroma Technology 
Corp., Bellows Falls, VT, USA) mounted into the Lambda 
10-B Filter wheel (Sutter Instruments Company, Novato, 
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Fig. 1 Experimental design for assessing the chloride extrusion activity of the K–Cl cotransporter KCC2 in neuronal cells. a Schematic depiction 
of the Cl-sensor. Cl-sensor consists of a triple YFP mutant fused via a short 20 amino acid linker with the CFP protein. b Schematic picture of the 
inverted fluorescence imaging setup used in the study. Grown on a coverslip, Neuro-2a cells were perfused with extracellular solution (ECS) in the 
absence and then in the presence of furosemide. Combination of high [K+] and glycine (with and without furosemide) was applied via the local 
perfusion system during the chloride-loading step. Details of the excitation and emission filters are described in the “Methods” section. c Represent-
ative optic view of Neuro-2a cells consequently excited with the 430 and 500 nm light. Regions of interest (ROIs) used for the subsequent analysis of 
the emitted fluorescence intensities for this optic view are indicated by yellow circles
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USA). A transmission neutral density filter (ND 1.3 
B–5% Trans, Chroma Technology Corp.) was installed 
in front of 430(24) nm excitation filter to prevent inac-
tivation of the Cl-sensor by 430 nm light [57]. Olympus 
LUCPlanFLN 20× objective, NA 0.45 (Olympus, France) 
was used for taking images of 10–20 cells simultane-
ously (Fig. 1c). The emitted fluorescence passed through 
a double bandpass [470(24)  +  535(30)] filter (59017  m 
was purchased as a part of the #59217 set, Chroma Tech-
nology Corp., Bellows Falls, VT, USA) and was collected 
using CoolSNAPHQ Monochrome CCD camera with 
0.05  Hz acquisition frequency and 20–50  ms exposure 
time. Intensities of the collected fluorescent signals cor-
responding to the excitation wavelengths of 430 nm (F430) 
and 500  nm (F500) were corrected for background fluo-
rescence. For that, three ROIs were chosen in nonfluo-
rescent areas for each analyzed optic view. Fluorescent 
intensities measured for three ROIs were averaged (sepa-
rately for 430 and 500 nm) to obtain the background val-
ues that were subsequently subtracted from F430 and F500 
values obtained for ROIs corresponding to the measured 
cells from the same optic view. Metamorph software with 
an option for a multi-dimensional acquisition (MDA) 
(Roper Scientific SAS, Evry, France) was used to calculate 
a background-corrected ratio R = F430/F500.
Fluorescence recording protocol
Coverslips with Neuro-2a cells overexpressing GlyR ɑ1 
subunit were fixed inside the imaging chamber, which 
was mounted onto the inverted Olympus fluorescence 
microscope. Cells were perfused with an extracellular 
solution ECS (in mM): 150 NaCl, 2.5 KCl, 2.0 CaCl2, 2.0 
MgCl2, 5 HEPES, 10 d-glucose, pH 7.4 using a fast perfu-
sion system described previously [60]. An inner diameter 
of the quartz perfusion tubes (250  μm) allowed a rapid 
(within 100 ms) change of solutions in the entire optical 
field. Bumetanide (10  μM) was added into all solutions 
to prevent chloride influx mediated by NKCC1 cotrans-
porter. Chloride loading of Neuro-2a cells was accom-
plished by applying ECS supplemented with 100  μM 
glycine. Simultaneously with applying glycine, [K+] in the 
ECS was raised up to 50 mM to increase Cl− driving force 
and thus to elevate efficiency of Cl− loading process. This 
was done by substituting [Na+] for [K+] in the ECS to 
keep osmolarity of the final solutions equal 310  mOsm. 
All experiments were performed at room temperature 
(22–24 °C).
Calibration
Cl-sensor was calibrated in Neuro-2a cells as described 
previously [45]. Coverslips were placed in experimen-
tal chamber connected to a perfusion system described 
above. Neuro-2a cells were permeabilized for 5–10  min 
with 80  mM β-escin (Sigma, St. Louis, USA) added to 
the extracellular solution (in mM) (150 NaCl, 2.5 KCl, 
2.0 CaCl2, 2.0 MgCl2, 5 HEPES, 10 d-glucose, pH 7.4). 
Calibration solutions containing different [Cl−] (5, 15, 
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Fig. 2 Calibration of the Cl-sensor in Neuro-2a cells. a Ratio for 
intensities of fluorescent signals emitted by Neuro-2a cells express-
ing Cl-sensor after excitation with 430 nm (F430) and 500 nm (F500) 
light. Neuro-2a cells were permeabilized with β-escin and incubated 
in extracellular solutions containing different Cl− concentrations 
[Cl−]o. An example of stepwise [Cl
−]o changes is shown. Acquisition 
interval is 20 s. Mean values and the corresponding SEM are shown 
for 12 cells recorded in the optic field. b A linear regression for F430/
F500 changes Δ(F430/F500) obtained for a broad range of [Cl
−]o changes 
(Δ[Cl−]o) derived from multiple (n = 8) independent experiments 
similar to one shown in (a). Each data point shows how the F430/F500 
ratio changes in response to a change of the extracellular chloride 
concentration Δ[Cl−]o. Error bars represent SEM. Error bars correspond-
ing to −10, +5, and +10 mM data points are too small to be seen on 
the graph
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50, 100, and 150 mM) were prepared by mixing solutions 
with a high chloride concentration (150 mM KCl, 10 mM 
d-glucose, 20  mM HEPES, pH 7.3) and zero chloride 
concentration (150 mM K-Gluconate, 10 mM d-glucose, 
20  mM HEPES, pH 7.3). The calibration solutions were 
applied into the experimental chamber through a perfu-
sion system, and intensities of fluorescence F430 and F500 
emitted after excitation of Neuro-2a cells with wave-
lengths 430 and 500 nm were measured. Incubation time 
in each of the calibration solutions was about 2–3 min to 
reach steady-state values for F430 and F500 signals.
Statistical analysis
All results are presented as mean ± SEM. The statistical 
significance was assessed by ANOVA using GraphPad 
Prizm software (GraphPad Software, CA, USA).
Results
Calibration of the Cl‑sensor in cultured Neuro‑2a cells
We aimed to develop a robust optical technique for meas-
uring K–Cl transport activity mediated by electroneutral 
K–Cl cotransporter KCC2 in neuronal cells. In contrast 
to other available optical approaches, we intended to 
assess chloride fluxes through a plasma membrane rather 
than a steady-state intracellular chloride concentra-
tion [Cl−]i, as the latter one does not necessarily reflect 
KCC2 activity properly. Since a regular transport mode 
of KCC2 is known to be chloride extrusion, we developed 
our protocol to measure chloride efflux similar to the 
previously published efflux assays [16, 61, 62]. To visual-
ize [Cl−]i dynamics in Neuro-2a cells, we used Cl-sensor, 
a genetically encoded sensor characterized previously 
[45, 55, 57]. To calibrate the Cl-sensor for the subsequent 
flux experiments, we modelled a situation that occurs in 
Neuro-2a cells, when the chloride flux is generated as a 
result of the efflux activity of the K–Cl cotransporter. To 
calibrate Cl-sensor, Neuro-2a cells grown on glass cover-
slips and expressing Cl-sensor, were permeabilized with 
β-escin [55] and incubated sequentially in a series of 
HEPES-buffered solutions with chloride concentrations 
[Cl−]o varying from 5 to 150  mM. Cells were sequen-
tially illuminated by 500 and 430  nm light, and intensi-
ties of the fluorescent signals emitted by the Cl-sensor 
(F430 and F500), passed through a double bandpass filter 
[470(24)  +  535(30)], were recorded (Fig.  1). The cor-
responding ratio R  =  F430/F500 was calculated for each 
[Cl−]o (Fig.  2a). The changes in the extracellular (and 
in intracellular due to the β-escin permeabilization) 
chloride concentrations produced the corresponding 
changes ΔR. Figure  2a represents an example of one of 
such experiments, where we applied in series the extra-
cellular solutions with different [Cl−]o (50, 15, 5, 50, 
100, 150, and 5  mM) to the Neuro-2a cells expressing 
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Cl-sensor and permeabilized with β-escin. Such graphs 
allowed us to calculate ΔR values for the correspond-
ing Δ[Cl−]o changes. Of note, ΔC values can be negative 
if [Cl−]o decreases at the subsequent step, or positive 
in the opposite situation; similarly, ΔR values can also 
be positive or negative. Experiments similar to the one 
shown in the Fig.  2a were performed totally with eight 
35  mm dishes (in two independent Neuro-2a cultures), 
and more than 80 Cl-sensor positive cells were recorded. 
In these experiments the extracellular solutions with 
varying [Cl−]o, were applied in various orders, and the 
obtained ΔR values were plotted as a function of Δ[Cl−]o 
(Fig.  2b). Nonphysiological Δ[Cl−]o values (>100  mM) 
have not been analyzed. The obtained (Δ[Cl−]o, ΔR) 
pairs were fitted by the linear regression with the equa-
tion Y  =  0.0152*X  −  0.0834 (r2  =  0.99). In agreement 
with Stern–Volmer equation, ΔR demonstrated a linear 
dependence in the broad range of alterations Δ[Cl−]o 
with the slope k = ΔR/Δ[Cl−]o = 0.015 (Fig. 2b), though 
inconsistency in ΔR determination increased for Δ[Cl−]o 
values larger than ± 50 mM. We did not use a nonlinear 
regression analysis, since the linear regression occurred 
to be accurate enough for modelling our data in the 
indicated interval of the chloride changes (<100  mM). 
In addition, in the case of linear regression, just a single 
coefficient (k, angle of inclination) is used to transform 
Δ(F430/F500) into the corresponding changes of the 
intracellular chloride concentration ΔC.
Protocol for chloride loading in Neuro‑2a cells
One of the strategies for measuring KCC2 activity is to 
estimate how efficiently KCC2 copes with the artificially 
elevated [Cl−]i level. Chloride loading in such experi-
ments has been successfully accomplished through 
sharp electrodes [21], patch-clamp glass pipettes [16, 
62], and via opening chloride channels of GABAA and 
Gly receptors upon application of the corresponding 
agonists [45, 55, 57, 63]. The latter approach allows to 
change [Cl−]i in multiple cells simultaneously, thus it 
was a method of choice for our experiments. Neuro-2a 
cells were transiently transfected with the expression 
construct for GlyR ɑ1 subunit. When expressed in het-
erologous system, these subunits can form functional 
homo-oligomeric chloride channels [64] with high Cl− 
conductance [65]. To enable chloride loading, trans-
fected cells were first pre-incubated in standard ECS for 
5  min and then perfused with ECS containing glycine 
(100 µM) (an arrow in Fig. 3a). ΔR values were recorded 
every 20 s and transformed into Δ[Cl−]i using the slope 
coefficient k obtained during the calibration procedure. 
Only minor changes Δ[Cl−]i were detected in Neuro-
2a cells expressing ɑ1 GlyR upon application of glycine 
(Fig.  3a). This could be explained by a relatively high 
basal [Cl−]i level (about 60  mM) in Neuro-2a cells [66] 
and, as a consequence, by a relatively weak inward driv-
ing force for chloride. To increase the driving force, we 
shifted the resting membrane potential (RMP) to more 
depolarized values simultaneously with the application 
of glycine (Fig. 3b). For this purpose, Na+ in the extra-
cellular solution was substituted for K+ to increase 
concentration of the latter up to 50 mM, while keeping 
osmolarity constant. Indeed, in high K+ conditions we 
observed a fast and efficient chloride loading in Neuro-
2a cells (Fig. 3b). Also, in agreement with previous stud-
ies [45, 55, 57], we noticed that high K+ itself can induce 
Cl− loading in Neuro-2a cells even in the absence of gly-
cine application, though a rate of Cl− loading was about 
twice lower (Fig. 3c). This may be explained by unusually 
high chloride permeability of Neuro-2a cells reported 
previously [66] or by the KCl-induced depolarization 
and subsequent acidification of the intracellular com-
partments. A combination of high K+ and glycine have 
been used in all subsequent experiments for efficient Cl− 
loading into Neuro-2a cells.
Furosemide‑sensitive chloride efflux mediated by KCC2a 
and KCC2b isoforms in Neuro‑2a cells
To measure chloride efflux mediated specifically by 
KCC2, Neuro-2a cells were loaded with Cl− as described 
above, and kinetics of the subsequent [Cl−]i recovery to 
the baseline level was analyzed sequentially in absence 
and then in presence of furosemide, a known inhibitor of 
the K–Cl cotransporters [67]. ΔR values were recorded 
every 20  s and transformed into changes Δ[Cl−]i using 
the coefficient k derived from calibration procedure 
(Fig.  2). After 4  min period of baseline recording in 
(See figure on previous page.) 
Fig. 4 Kinetics of the Cl− extrusion in KCC2a-, KCC2b-, and mock- transfected Neuro-2a cells. Recordings of [Cl−]i changes (Δ[Cl
−]i) in Neuro-2a cells 
transfected with KCC2a (a), KCC2b (b), and empty vector (c) constructs. Left panels show individual recordings of representative cells for each of the 
constructs; right panels demonstrate quantifications of the individual recordings. After initial baseline acquisition (4 min), cells were loaded with 
chloride by applying 100 µM glycine in 50 mM K+ ECS (10 min). Washing cells with normal K+ ECS for 5–10 min was accompanied by rapid decrease 
in [Cl−]i. The rate of the chloride extrusion Δ[Cl
−]i/Δt was much faster in cells transfected with KCC2a (a) and KCC2b (b) constructs compared to 
the mock-transfected cells (c). In the second phase of the experiment, the whole procedure was repeated in the presence of 500 µM furosemide, a 
known inhibitor of K–Cl cotransport. The initial rate of [Cl−]i reduction (mM/min) was calculated using the first half of each slope. For each individual 
cell, the rate of furosemide-sensitive Cl extrusion was calculated as a difference between the corresponding rates of [Cl−]i extrusion in the presence 
and absence of furosemide
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normal K+ ECS, cells were loaded with Cl− by applying 
glycine (100 µM) in high K+ ECS (Fig. 4a–c). To shorten 
the imaging protocol, Cl− loading step was restricted to 
10 min, even though in most cases this duration was not 
enough to reach a plateau level. Cl− loading was followed 
by substitution of the high K+ ECS solution for the one 
with normal K+ and containing no glycine that leaded to 
the fast [Cl−]i recovery to the basal level in cells trans-
fected with KCC2a (Fig. 4a) and KCC2b (Fig. 4b), but not 
with empty vector (Fig. 4c). A linear regression was used 
to determine a rate of [Cl−]i recovery Δ[Cl−]i/Δt (red 
lines in Fig.  4a–c), and the corresponding slopes were 
calculated (red bars on the right panels of Fig. 4a–c). The 
steep drop of [Cl−]i for KCC2a and KCC2b expressing 
cells can be partly attributed to the KCC2-mediated chlo-
ride extrusion and partly to the Cl− efflux via chloride 
channels and other than KCC2 transporters as a result of 
the change in the driving force for chloride. Bumetanide 
(10 µM) was added into all solutions to block the activity 
of Na+–K+–2Cl− cotransporter NKCC1, which is known 
to be endogenously expressed in Neuro-2a cells [66] and 
also known to mediate chloride influx. In the second part 
of the recording, the Cl− loading and Cl− recovery steps 
were repeated in the presence of 500 µM furosemide to 
block the KCC2-specific efflux activity (green lines and 
bars in Fig. 4a–c). The furosemide-sensitive components 
of the Cl− extrusion for individual Neuro-2a cells (black 
bars in Fig. 4a–c) were derived by subtracting furosem-
ide(+) components from corresponding furosemide(−) 
components.
The average chloride efflux characterized by Δ[Cl−]i/
Δt was 2.9-fold higher in cells transfected with KCC2a 
and 2.3-fold in cells transfected with KCC2b constructs 
compared to the mock-transfected cells (grey bars in 
Fig.  5a). Previous studies reported ~2.7-fold increase 
for 86Rb+ uptake in HEK293 cells transiently transfected 
with either KCC2a or KCC2b isoforms [5], and ~fourfold 
increase in HEK293 stably transfected with KCC2b iso-
form [67]. Furosemide (500  µM) attenuated Cl− extru-
sion activity of KCC2a and KCC2b about fourfold, to the 
level detected in mock-transfected cells in the presence 
of furosemide (black bars in Fig.  5a). Of note, chloride 
fluxes in the mock-transfected cells also decreased ~1.9-
fold upon furosemide application that is in agreement 
with 86Rb+ flux data reported previously for mock-trans-
fected HEK293 cells [5, 67]. Furosemide-sensitive com-
ponents of Δ[Cl−]i/Δt values were considerably higher 
in Neuro-2a cells transfected with KCC2a (6.3-fold) and 
KCC2b (5.5-fold) constructs compared to the mock-
transfected control, but did not differ significantly from 
each other (Fig. 5b). These values were close to the ones 
reported previously for the 86Rb influx in HEK293 cells 
stably transfected with KCC2b (6.2-fold) [67], as well as 
for the 86Rb influx in HEK293 cells transiently transfected 
with KCC2a (~fourfold) and KCC2b (~fourfold) [5, 58].
The above experiments showed that even the relatively 
short Cl− loading step (~10  min) leads to a significant 
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Fig. 5 Exogenously expressed KCC2a and KCC2b mediate efficient 
furosemide-sensitive chloride extrusion in Neuro-2a cells. a Mean 
values for the Cl− extrusion rate in the presence and absence 
of furosemide obtained in the individual experiments similar to 
those shown in Fig. 4. The rate of chloride extrusion is significantly 
decreased by furosemide (500 μM), a known blocker of K–Cl trans-
port, in KCC2a (n = 55) and KCC2b (n = 40) transfected cells.  
(*** p < 0.005; ns, nonsignificant; two-sided Student’s t-test; Error 
bars represent SEM). b Neuro-2a cells expressing KCC2a (n = 55) 
and KCC2b (n = 40) constructs demonstrate a significantly higher 
furosemide-sensitive Cl− extrusion rate compared to the mock 
transfected cells (n = 20). (*p < 0.05; ***p < 0.005; ns nonsignificant; 
Kruskal–Wallis nonparametric ANOVA). Mean values and correspond-
ing SEM are shown
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[Cl−]i increase that could affect multiple intracellular 
signaling pathways. Previous studies have reported an 
important role of the WNK-SPAK signaling pathway in 
the regulation of the K–Cl cotransport activity mediated 
by KCC2: the pathway is known to be fully activated after 
30–60  min preincubation in low [Cl−]i [68, 69], result-
ing in KCC2 inhibition [17, 18, 70, 71]. In contrast, the 
high [Cl−]i is known to inhibit SPAK kinase [20], thus 
leading to the KCC2 activation. Therefore, the Cl− load-
ing step could theoretically lead to the inhibition of the 
WNK-SPAK pathway and, consequently, to the KCC2 
activation, thus affecting the KCC2 transport activity. 
To address this question, we modified our protocol and 
included two consecutive chloride-loading steps without 
the furosemide, and then one loading step with the furo-
semide. Extrusion kinetics after the first and second chlo-
ride-loading steps have been compared for both KCC2a 
and KCC2b isoforms. For both KCC2 isoforms, we 
revealed a tendency to the increase of the extrusion rate 
during the second step compared to the first step, but it 
was not significant (KCC2a: 61 ±  15%, p =  0.055, Stu-
dent’s t-test, 47 cells in 3 experiments; KCC2b: 54 ± 25%, 
p = 0.16, Student’s t-test, 71 cell in 3 experiments). It is 
important to notice that during our standard protocol 
(with one chloride-loading step without furosemide and 
one with furosemide) the tendency to the increase of the 
extrusion rate cannot distort our measurements, as the 
KCC2 activity at the second step is anyway blocked by 
the furosemide.
The 10 min chloride loading protocol was used in our 
study, since it provided the robust [Cl−]i increase for the 
reasonably short period. The data presented in Fig.  4 
also imply that shorter loading protocols can be used 
to minimize [Cl−]i changes and subsequent effects on 
intracellular signaling pathways (e.g. WNK-SPAK). To 
check whether the chloride extrusion rate depends on the 
amount of chloride preloaded during the loading step, we 
compared the short (2-min) and long (10-min) loading 
protocols. For the KCC2a-transfected cells in the absence 
of furosemide, an average increase in the [Cl−]i during 
the 2-min loading step (5.8 ±  0.14 mM, n =  15 cells in 
N = 4 experiments) was significantly lower (p = 0.0052, 
Student’s t-test) compared to the 10-min loading protocol 
(14.1 ± 1.6 mM, n = 57 cells in N = 6 experiments). In 
the same conditions, the chloride efflux activity after the 
2-min loading procedure (7.3  ±  0.24  mM/min, n  =  15 
cells in N = 4 experiments) was not significantly different 
(p = 0.19, Student’s t-test) compared to the efflux activity 
after the 10-min loading step (8.4 ± 1.6 mM/min, n = 57 
cells in N = 6 experiments). For the KCC2a-transfected 
cells in the presence of furosemide, an average increase 
in the [Cl−]i for the 2-min loading step (6.9 ± 0.37 mM, 
n = 25 cells in N = 4 experiments) was significantly lower 
(p  =  0.035, Student’s t-test) compared to the 10-min 
loading (13.4  ±  2.1  mM, n  =  51 cell in N  =  6 experi-
ments). However, the chloride efflux activity after the 
2-min loading procedure (2.6  ±  0.36  mM/min, n  =  15 
cells in N =  4 experiments) was not significantly differ-
ent (p  =  0.59, Student’s t-test) compared to the efflux 
activity after the 10-min loading step (2.4 ± 0.6 mM/min, 
n = 51 cells in N = 6 experiments). Importantly, in both 
cases (2-min and 10-min loading) we did not observe sig-
nificant difference for amount of chloride loaded in the 
presence and absence of furosemide. For the 2-min load-
ing step: (−furo) 5.8 ± 0.14 mM, n = 15 cells in N = 4 
experiments versus (+furo) 6.9 ± 0.37 mM, n = 25 cells 
in N = 4 experiments, p = 0.07, Student’s t-test. For the 
10-min loading step: (−furo) 14.1 ± 1.6 mM, n = 57 cells 
in N  =  6 experiments versus (+furo) 13.4  ±  2.1  mM, 
n  =  51 cell in N  =  6 experiments, p  =  0.8, Student’s 
t-test. Thus, we conclude that the efflux activity of the 
KCC2a cotransporter does not depend on the amount of 
chloride pre-loaded into the cells. In addition, these data 
show that furosemide does not affect significantly the 
amount of chloride loaded during the loading step.
Discussion
In this study we have described a straightforward tech-
nique for assessing efflux activity mediated by K–Cl 
cotransporter KCC2 in neuronal cells. Our protocol 
ensures following features: (1) physiologically relevant 
chloride sensitivity, (2) direct assessment of furosemide-
sensitive chloride fluxes instead of a steady-state chloride 
concentration, (3) measurement of chloride efflux instead 
of influx, (4) minimal impact of intracellular signaling 
pathways (e.g. SPAK/OSR1), (5) noninvasiveness, and (6) 
high throughput. While some of these features individu-
ally can be attributed to currently known methods for 
assessing KCC2 activity, none of the existing methods to 
our knowledge has so far combined all these features.
As a basis for our technique, we have chosen an opti-
cal approach and implemented it by means of the pre-
viously characterized Cl-sensor, a triple YFP mutant 
H148Q/I152L/V163S [45]. Optical approaches in general 
are known to provide low toxicity, noninvasiveness, and 
high efficiency. Although expression level of Cl-sensor 
in our experiments was high enough for stable record-
ings of chloride fluxes, no signs of cytotoxicity were 
observed. Morphology of Neuro-2a cells expressing Cl-
sensor was normal and did not differ from that of non-
transfected cells. Cl-sensor in combination with our 
imaging setup, which is equipped with 20× objective, 
allowed us to measure simultaneously the furosemide-
sensitive chloride fluxes in about 15 transfected cells 
during our standard (about 40  min) recording proto-
col. Similar throughput has been previously observed in 
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studies that used Cl-sensor in dissociated cultures [45, 
55, 57], brain and retina slices [55], and ex  vivo whole-
mount DRG samples [49]. More cells can be analyzed by 
using objectives with lower magnification, but this may 
require increasing an acquisition time and/or intensity 
of light sources. Both these factors affect accuracy of Cl− 
measurements [57], partially because YFP and CFP com-
ponents of Cl-sensor have differential photobleaching 
rates [51, 72]. Thus, to prevent photobleaching we kept 
acquisition time (20–50 ms) and rate (0.05 Hz) minimal. 
For cells with a very high KCC2 activity, time required for 
restoration of [Cl−]i to the basal level may become too 
short, thus temporal resolution of the acquisition process 
may need to be increased. Intrinsic properties of the YFP 
mutant utilized for Cl-sensor design impose an upper 
limit for an acquisition rate of about 0.5  Hz [38], thus 
temporal resolution can be further increased.
Development of GECS has been significantly intensi-
fied during last decade, and different chloride sensors 
have been used for measuring steady-state [Cl−]i lev-
els in mammalian cells [35]. However, it has previously 
been noticed that the steady-state [Cl−]i level itself does 
not necessarily reflect KCC2 extrusion activity properly, 
as in the conditions of low chloride conductance even a 
relatively weak KCC2 activity may significantly decrease 
[Cl−]i [16, 62]. Thus, we used Cl-sensor to assess KCC2-
mediated chloride efflux by measuring directly Δ[Cl−]i in 
time. This approach required a different calibration pro-
tocol for Cl-sensor: while a standard calibration estab-
lishes relationship between absolute values of F430/F500 
ratio and [Cl−]i, our protocol determines a link between 
changes ΔR of the F430/F500 ratio and changes Δ[Cl−]i 
(Fig.  2b). Changes in [Cl−]i were induced by applying 
calibration solutions with predefined chloride concentra-
tions [Cl−]o to Neuro-2a cells permeabilized with β-escin. 
Importantly, ΔR and Δ[Cl−]i were linearly related that is 
in agreement with previous studies [73], although incon-
sistency in ΔR determination increased outside physi-
ological range for Δ[Cl−]i values larger than  ±  50  mM 
(Fig. 2b). The angle of inclination between the regression 
line and x-axis allowed us to estimate dissociation con-
stant Kd defined according to the Stern–Volmer equa-
tion as R0/Kd, where R0 is F430/F500 ratio at zero chloride 
concentration. Dissociation constant for the Cl-sensor 
in Neuro-2a cells was found to be ~60 mM that is close 
to the previously calculated Kd  ~  50  mM for Cl-sensor 
in cultured neurons [55] as well as for other double and 
triple YFP mutants analogous to Cl-sensor [38]: H148Q/
I152L (~90  mM), H148Q/V150A/I152L (~60  mM), and 
H148Q/V163S (~60  mM). The calculated Kd  ~  60  mM 
is close to the value of the basal [Cl−]i level in Neuro-2a 
cells [66], thus making Cl-sensor suitable for assessing 
chloride fluxes in this model system.
Our protocol includes Cl− loading in Neuro-2a cells 
with subsequent analysis of how fast KCC2 brings down 
[Cl−]i to the basal level. Previous studies showed that 
certain GluR subunits form functional homo-oligomeric 
glycine receptors possessing high Cl− conductance. We 
used ɑ1 subunit of GlyR to load Neuro-2a cells with Cl− 
upon application of glycine. Preliminary experiments 
showed that Cl− loading was relatively weak that could 
be explained by a relatively high basal [Cl−]i in Neuro-2a 
cells. To make the loading process more efficient, in par-
allel with glycine application we elevated resting mem-
brane potential by substituting extracellular Na+ for K+ 
in ECS medium (high K+ medium). The K+-induced 
depolarization is known to result in [Ca2+]i increase 
that in turn, via Ca2+-ATPases, could result in acidifica-
tion up to 0.2 pH units [74]. Since all YFP-based chloride 
sensors are known to be pH sensitive, the K+-induced 
depolarization may affect the Cl-sensor recordings. By 
using Cl-free solutions, the pH-associated Δ[Cl−]i val-
ues, reported by Cl-sensor, were estimated to be ~5 mM 
for the 4  min acidification interval [45]. Slightly higher 
Δ[Cl−]i values (~7 mM) have been observed in our sys-
tem for the same 4 min acidification interval (Fig. 3c). In 
contrast to the Markova and coauthors, we did not sub-
stitute chloride by gluconate in our solutions, thus the 
slightly increased Δ[Cl−]i values could be attributed, for 
example, to the increased Cl-influx activity of the chlo-
ride channels/transporters in the Neuro-2a cells upon 
the increased driving force induced by KCl application. 
This approach resulted in a robust Cl− load, increasing 
intracellular concentration by ~15–20  mM in Neuro-2a 
cells expressing KCC2 constructs and ~10–15 mM in the 
mock transfected cells (Fig. 4). Importantly, amplitude of 
[Cl−]i changes during the Cl− loading procedure did not 
exceed the ±50 mM range of the standard curve (Fig. 2b) 
that represents a linear interval of dependence between 
ΔR and Δ[Cl−]i. Higher efficiencies of the Cl− loading 
in KCC2-expressing cells compared to the mock-trans-
fected cells could be explained by the inverted mode of 
KCC2-mediated transport in the conditions of elevated 
K+, as it was predicted previously [67]. Even though the 
inverted mode (influx) is commonly used to assess K–
Cl cotransport activity mediated by KCC2 and other 
members of CCC family, we are not aware of any studies 
demonstrating that these two approaches are equivalent. 
Thus, we optimized our approach according to previous 
studies that measured KCC mediated chloride efflux [61, 
62, 75, 76].
The idea of our approach has been borrowed from 
another method for assessing the chloride extrusion/
intrusion activity—rubidium assay, which is widely 
used in the chloride-cotransporter field for decades. 
According to the methodology of the rubidium assay, a 
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conclusion about the transporter activity can be made on 
the bases of two measurements: (1) in normal conditions, 
and (2) in the same conditions, but in the presence of the 
inhibitor for the transporter of interest. It is important to 
note that the rubidium flux through a plasma membrane 
is mediated not only by the activity of the transporter of 
interest, but also through dozens of other channels and 
transporters endogenously expressed in the model sys-
tem. Therefore, an estimation of individual impacts of 
each of these channels/transporters would be extremely 
laborious and complex. Instead, a transport activity of a 
protein of interest is calculated by subtracting the trans-
port activities in the absence and in the presence of the 
inhibitor. The same approach is used in our method, and 
it is the main dignity of our method that it eliminates 
necessity to meticulously calibrate Cl-sensor depend-
ence on numerous parameters, some of which possibly 
have not been even recognized yet. Indeed, we are still 
not aware about all characteristics of the Cl-sensor and 
its dependence on any other factors except pH. We also 
do not know how other biologically significant intracel-
lular components and cascades affect the Cl-sensor. That 
is why we proposed to assess chloride fluxes using the Cl-
sensor first in standard conditions and immediately after 
that in the presence of furosemide, a well-known KCC2 
inhibitor.
Changing ECS medium to the one with normal K+ 
and without glycine resulted in a rapid chloride efflux 
via KCC2-dependent and, possibly, via some KCC2-
independent mechanisms. The latter component, rep-
resented by chloride channels and transporters other 
than KCC2, was measured by repeating the experiment 
in the presence of furosemide, a known inhibitor of K–
Cl cotransporters. The furosemide(+) component of the 
efflux was relatively high (Fig. 5a), thus confirming a pre-
viously known high chloride permeability of Neuro-2a 
cells [66]. Average values of the furosemide(+) compo-
nents measured in KCC2a, KCC2b, and mock transfected 
cells were comparable (Fig.  5a), indicating that 500  µM 
furosemide blocked efficiently both KCC2a and KCC2b 
mediated chloride transport. Furosemide concentra-
tions up to 2 mM were used previously to block activity 
of KCC2 and other K–Cl cotransporters in cell lines and 
oocytes [5, 32, 57, 77–80], despite the fact that original 
studies in HEK293 cells identified Ki for furosemide to be 
around 25 µM for KCC2 [67] and 40 µM for KCC1 [61]. 
Even though the inhibitory effect of furosemide in the 
mock-transfected cells was not significant, a clear ten-
dency towards downregulation of the chloride extrusion 
rate was observed (Fig.  5a) indicating that endogenous 
expression of K–Cl cotransporters in Neuro-2a cells can-
not be excluded. Indeed, we have previously reported a 
weak endogenous expression of KCC2 in Neuro-2a cells 
[81] that could be further increased upon differentia-
tion of Neuro-2a cells by retinoic acid (data not shown). 
A similar inhibitory effect of furosemide in mock-trans-
fected cells has been reported for HEK293 cells [5, 67, 79] 
in agreement with data showing endogenous KCC1 and 
KCC4 expression in HEK293 cells [82]. We found that 
the furosemide-sensitive chloride efflux was considerably 
higher in Neuro-2a cells transfected with KCC2a (6.3-
fold) and KCC2b (5.5-fold) constructs compared to the 
mock-transfected control, but did not differ significantly 
from each other (Fig.  5b). These values are close to the 
ones reported previously for the 86Rb influx (6.2-fold) in 
HEK293 cells stably transfected with KCC2b [67] as well 
as for the 86Rb influx in HEK293 cells transiently trans-
fected with KCC2a (~fourfold) and KCC2b (~fourfold) 
[5].
Conclusions
In this study we presented a robust and reliable approach 
for measuring K–Cl transport activity mediated by neu-
ronal cotransporter KCC2. Our noninvasive approach 
proved to be efficient for measuring physiologically rel-
evant chloride concentrations, allowed direct assessment 
of furosemide-sensitive chloride fluxes, and in contrast 
to many existing techniques allowed to assess chloride 
efflux instead of influx. We used this method to compare 
transport activities of the N-terminal splice isoforms 
KCC2a and KCC2b in neuronal cells. Results obtained 
with our approach matched well to the results acquired 
previously using standard methods.
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